
“E-cigarettes were also associated with less successful quitting during that time frame,” said Pierce, a professor emeritus of family medicine and public health. In fact, nearly 60% of recent former smokers who were daily e-cigarette users had resumed smoking by 2019, the new study found.
“There’s no evidence that the use of e-cigarettes is an effective cessation aid,” Pierce said.
Uptick in use by teens
Proponents of e-cigarettes as a smoking cessation tool say higher-nicotine versions should assist tobacco cigarette smokers to quit tobacco cigarettes because they would be able to take fewer puffs off a vape than smoking the entire cigarette, Pierce said.
“In 2017, cigarette sales increased by 40%,” with a majority of the market share being held by new brands of e-cigarettes with very high nicotine levels, he said.
“We wanted to look at these new high-nicotine versions and see whether there’s any evidence that they helped people quit because the previous ones didn’t.”
Instead of an uptick in use by smokers, the study found use of e-cigarettes as a cessation aid dropped by 25% over the two-year period, Pierce said.
Did the higher-octane e-cigarettes help those who did use them to stop smoking?
“We can’t study the effectiveness of these high-nicotine e-cigarettes because no smokers were using them during the majority of the two-year period,” Pierce said. There was a small uptick in 2019, he added, which will need to be analyzed when the next PATH data are released.
If smokers weren’t driving the uptick in sales during 2017 to 2019, who was?
The FDA told CNN that the agency doesn’t comment on specific studies, but “evaluates them as part of the body of evidence to further our understanding about a particular issue and assist in our mission to protect public health.”
“The FDA is reviewing the findings of the paper,” said FDA press officer Alison Hunt via email.